As of Oct 26
| -0.02 / -0.32%|
The 5 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 14.00, with a high estimate of 18.00 and a low estimate of 12.00. The median estimate represents a +126.17% increase from the last price of 6.19.
The current consensus among 5 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.